Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Sea Limited
SE
|
$874M |
| 2 |
Coupang
CPNG
|
$809M |
| 3 |
Roblox
RBLX
|
$363M |
| 4 |
Analog Devices
ADI
|
$309M |
| 5 |
Adobe
ADBE
|
$255M |
Top Sells
| 1 |
Tesla
TSLA
|
$1.06B |
| 2 |
Petrobras
PBR
|
$460M |
| 3 |
Alibaba
BABA
|
$450M |
| 4 |
Zillow
Z
|
$381M |
| 5 |
NVIDIA
NVDA
|
$379M |
Sector Composition
| 1 | Consumer Discretionary | 28.1% |
| 2 | Healthcare | 23.85% |
| 3 | Technology | 19.62% |
| 4 | Communication Services | 11.36% |
| 5 | Financials | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTLS
251
Materialise
MTLS
$292M
| $5.19M | ﹤0.01% |
268,000
| – | – |
|
|
CLLS
252
Cellectis
CLLS
$269M
| $4.91M | ﹤0.01% |
1,082,095
+2,584
| +0.2% | +$11.7K |
|
|
TRHC
253
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $4.79M | ﹤0.01% |
831,690
-249,807
| -23% | -$1.44M |
|
254
Lyft
LYFT
$6.91B
| $4.64M | ﹤0.01% |
120,721
-7,444,760
| -98% | -$286M |
|
255
Bilibili
BILI
$9.25B
| $4.25M | ﹤0.01% |
165,946
-56,879
| -26% | -$1.46M |
|
256
Lyell Immunopharma
LYEL
$233M
| $3.96M | ﹤0.01% |
39,237
+3,068
| +8% | +$310K |
|
257
JD.com
JD
$44.6B
| $3.96M | ﹤0.01% |
68,377
-1,678,176
| -96% | -$97.1M |
|
|
NCNA
258
NuCana
NCNA
$5.48M
| $3.66M | ﹤0.01% |
732
| – | – |
|
259
Adicet Bio
ACET
$60M
| $3.63M | ﹤0.01% |
181,626
| – | – |
|
|
SOHU
260
Sohu.com
SOHU
$467M
| $3.37M | ﹤0.01% |
200,140
| – | – |
|
|
SAGE
261
DELISTED
Sage Therapeutics
SAGE
| $3.27M | ﹤0.01% |
98,766
+8,394
| +9% | +$278K |
|
262
American Well
AMWL
$113M
| $2.95M | ﹤0.01% |
34,978
+4,014
| +13% | +$338K |
|
263
WEC Energy
WEC
$34.7B
| $1.9M | ﹤0.01% |
18,996
+1,430
| +8% | +$143K |
|
264
Newmont
NEM
$83.7B
| $1.87M | ﹤0.01% |
23,572
+3,400
| +17% | +$270K |
|
265
Spire Global
SPIR
$276M
| $1.82M | ﹤0.01% |
108,256
| – | – |
|
266
Fortis
FTS
$24.8B
| $1.68M | ﹤0.01% |
33,889
+2,557
| +8% | +$127K |
|
267
CarGurus
CARG
$3.59B
| $1.37M | ﹤0.01% |
32,336
+5,522
| +21% | +$234K |
|
268
Exelon
EXC
$43.9B
| $1.36M | ﹤0.01% |
28,452
-8,414
| -23% | -$401K |
|
269
Ameren
AEE
$27.2B
| $1.21M | ﹤0.01% |
12,931
+972
| +8% | +$91.1K |
|
|
KLDO
270
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $1.21M | ﹤0.01% |
733,525
+12,013
| +2% | +$19.8K |
|
271
Novanta
NOVT
$4.18B
| $1.13M | ﹤0.01% |
7,936
+760
| +11% | +$108K |
|
|
UXIN
272
Uxin Ltd
UXIN
$722M
| $1.1M | ﹤0.01% |
10,829
-6,932
| -39% | -$707K |
|
273
Varonis Systems
VRNS
$6.28B
| $1.08M | ﹤0.01% |
22,651
+3,960
| +21% | +$188K |
|
274
Summit Therapeutics
SMMT
$19.3B
| $1.07M | ﹤0.01% |
436,512
| – | – |
|
275
Wheaton Precious Metals
WPM
$47.3B
| $971K | ﹤0.01% |
20,416
| – | – |
|